Myriad Genetics to Release Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026

Core Insights - Myriad Genetics, Inc. will hold its fourth quarter and full year 2025 earnings conference call on February 23, 2026, at 4:30 pm ET, with earnings released after market close on the same day [1] - The company is participating in three upcoming investor healthcare conferences, including the TD Cowen 46th Annual Health Care Conference, the Leerink Partners Global Healthcare Conference, and the Barclays 28th Annual Global Healthcare Conference [3][5] Company Overview - Myriad Genetics is a leader in genetic testing and precision medicine, focusing on advancing health and well-being through genetic tests that assess disease risk and guide treatment decisions [4]